Cipla Limited has informed the Exchange regarding a press release dated May 13, 2026.
Press Release May 13 2026
Earlier from Cipla
- Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin HFA
- Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
- Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation
- Cipla strengthens US portfolio with the launch of generic Saxenda(R) (Liraglutide Injection) for weight management therapy